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Abstract
Viral quasispecies refers to a population structure that consists of extremely large num-
bers of variant genomes, termed mutant spectra, mutant swarms or mutant clouds. Fueled
by high mutation rates, mutants arise continually, and they change in relative frequency as
viral replication proceeds. The term quasispecies was adopted from a theory of the origin of
life in which primitive replicons) consisted of mutant distributions, as found experimentally
with present day RNA viruses. The theory provided a new definition of wild type, and a con-
ceptual framework for the interpretation of the adaptive potential of RNA viruses that con-
trasted with classical studies based on consensus sequences. Standard clonal analyses
and deep sequencing methodologies have confirmed the presence of myriads of mutant
genomes in viral populations, and their participation in adaptive processes. The quasispe-
cies concept applies to any biological entity, but its impact is more evident when the genome
size is limited and the mutation rate is high. This is the case of the RNA viruses, ubiquitous
in our biosphere, and that comprise many important pathogens. In virology, quasispecies
are defined as complex distributions of closely related variant genomes subjected to genetic
variation, competition and selection, and that may act as a unit of selection. Despite being
an integral part of their replication, high mutation rates have an upper limit compatible with
inheritable information. Crossing such a limit leads to RNA virus extinction, a transition that
is the basis of an antiviral design termed lethal mutagenesis.
Historical origins
Quasispecies theory was developed in the 1970’s by Manfred Eigen and Peter Schuster to
explain self-organization and adaptability of primitive replicons (we use the term replicon to
refer to any replicating entity), as an ingredient of hypercyclic organizations that link
genotypic and phenotypic information, as an essential step in the origin of life [1,2]. The the-
ory portrayed early replicon populations as organized mutant spectra dominated by a master
sequence, the one endowed with the highest fitness (replicative capacity) in the distribution. It
introduced the notion of a mutant ensemble as a unit of selection, thus emphasizing the rele-
vance of intra-population interactions to understand the response to selective constraints. One
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of its corollaries is the error threshold relationship, which marks the maximum mutation rate
at which the master (or dominant) sequence can stabilize the mutant ensemble. Violation of
the error threshold results in loss of dominance of the master sequence and drift of the popula-
tion in sequence space) [2–5].
The core quasispecies concepts are described by two fundamental equations: replication
with production of error copies, and the error threshold relationship (Fig 1). They capture two
major features of RNA viruses at the population level: the presence of a mutant spectrum, and
the adverse effect of an increase of mutation rate on virus survival, each with several deriva-
tions (Fig 2).
The existence of a mutant spectrum was experimentally evidenced first by clonal analyses
of RNA bacteriophage Qβ populations whose replication had been initiated by a single virus
particle. Individual genomes differed from the consensus sequence in an average of one to two
Fig 1. Fundamental equations of quasispecies and representation of mutant spectra. The equations are the mathematical expression of the major
concepts implied by quasispecies theory. The first equation describes the change of concentration of molecule i as a function of replication parameters, and
its production from other molecules of the same ensemble. The second equation is the error threshold relationship, indicating the maximum amount of
information (ʋmax) and the maximum average error rate pmax (p = 1- q; q is the copying fidelity) for maintenance of genetic information. Terms are
defined in the box on the right. Below, an evolving mutant spectrum (with mutations represented as symbols on the genomes), with an invariant consensus
sequence. Details in [2].
https://doi.org/10.1371/journal.pgen.1008271.g001
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Wikipedia Version https://en.wikipedia.org/wiki/
Viral_quasispecies.
mutations per individual genome [6]. Fitness of biological clones was inferior to that of the
parental, uncloned population, a difference also documented for vesicular stomatitis virus
(VSV) [7]. The replicative capacity of a population ensemble need not coincide with that of its
individual components. The finding that a viral population was essentially a pool of mutants
came at a time when mutations in general genetics were considered rare events, and virologists
associated a viral genome with a defined nucleotide sequence, as still implied today in the con-
tents of data banks [8]. The cloud nature of Qβ was understood as a consequence of its high
mutation rate, calculated in 10−4 mutations introduced per nucleotide copied [9], together
with tolerance of individual genomes to accept an undetermined proportion of the newly aris-
ing mutations, despite fitness costs. The error rate estimated for bacteriophage Qβ has been
confirmed, and is comparable to values calculated for other RNA viruses [10,11].
High mutation rates and quasispecies were verified for other RNA viruses based on dissec-
tion of viral populations by molecular or biological cloning, and sequence analysis of individ-
ual clones. John Holland and colleagues were the first to recognize that a rapidly evolving
Fig 2. Flow of conceptual derivations of quasispecies theory for viral populations, and some biological consequences.
https://doi.org/10.1371/journal.pgen.1008271.g002
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RNA world inserted in a DNA-based biosphere had multiple evolutionary and medical impli-
cations [12–14]. Genome plasticity of RNA viruses had been suspected for many decades. Key
early observations were variations in viral traits described by Findley in the 1930’s, the studies
of Granoff on transitions of plaque morphology of Newcastle disease virus, or the high fre-
quency of conversions between drug resistance and dependence in Coxsackie A9 virus, among
other studies with animal and plant viruses in the middle of the 20th century (for a historical
overview and references, see 15). When put in the context of present day knowledge, we realize
that these observations on phenotypic changes were the tip of the iceberg of an extremely com-
plex reality of viral populations. High mutation rates and population heterogeneity character-
ize RNA viruses, with consequences for viral pathogenesis and the control of viral disease.
Detailed studies on quasispecies dynamics in vivo have been performed with human
immunodeficiency virus type 1 (HIV-1) and hepatitis C virus [16–18].
Current scope of quasispecies
The first mathematical formulation of quasispecies was deterministic; it assumed steady state
mutant distributions in equilibrium without perturbations derived from modifications of the
environment or population size [2]. These conditions are common in initial theoretical formu-
lations of complex phenomena because they confer mathematical tractability. Since then, sev-
eral extensions of the theory to non-equilibrium conditions with stochastic components have
been developed, with the aim of finding general solutions for multi-peak fitness landscapes.
These objectives approximate quasispecies to the real case of RNA viruses, which are com-
pelled to deal with dramatic variations in population size and environment (reviewed in [19]).
Research on quasispecies has proceeded through several theoretical and experimental avenues
that include continuing studies on evolutionary optimization and the origin of life, RNA-RNA
interactions and replicator networks, the error threshold in variable fitness landscapes, consid-
eration of chemical mutagenesis and proofreading mechanisms, evolution of tumor cells, bac-
terial populations or stem cells, chromosomal instability, drug resistance, and conformation
distributions in prions (a class of proteins with conformation-dependent pathogenic potential;
in this case the quasispecies is defined by a distribution of conformations) [16,20]. New inputs
into experimental quasispecies research have come from deep sequencing to probe viral and
cellular populations, recognition of interactions within mutant spectra, models of viral
population dynamics related to disease progression and pathogen transmission, and new
teachings from fidelity variants of viruses (the several theoretical, experimental and practical
facets of quasispecies have been reviewed in several chapters of [20]). Here we summarize the
main aspects of quasispecies dynamics, and recent developments relevant to virus evolution
and pathogenesis.
Dynamic heterogeneity
The molecular basis of high error rates is the limited template-copying fidelity of RNA-
dependent RNA polymerases (RdRps) and RNA-dependent DNA polymerases (also termed
reverse transcriptases, RTs). In addition, these enzymes are defective in proofreading) [21]
because they lack a 3’ to 5’ exonuclease domain present in replicative cellular DNA polymer-
ases [22]. Also, postreplicative-repair pathways, abundant to correct genetic lesions in replicat-
ing cellular DNA, appear as ineffective for double-stranded RNA or RNA-DNA hybrids. The
presence of a proofreading-repair activity in coronaviruses increases their copying accuracy in
about 15-fold [23]. This and other repair activities, that may act on standard RNA or retroviral
genomes [24–27], do not prevent the formation of mutant spectra, although their amplitude
may be lower than for other RNA viruses, at least in populations close to a clonal (single
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genome) origin. Quasispecies dynamics will operate in any viral or cellular system in which
due to high mutation rates (as a result of low fidelity nucleic acid polymerases or environmen-
tal alterations) mutant spectra are rapidly generated [16,28–32].
Studies with different virus-host systems have established some general observations on the
mechanisms of mutant generation, and implications of quasispecies dynamics [16,20,33–41].
In RNA virus genetics when we speak of “a mutant” the entity we handle is a cloud of mutants
in which the specific mutation to which we direct our attention is present in all (or the great
majority of) individual genomes. There is no such a thing as “a” wild type or “a” mutant virus.
They are always clouds of mutants. Changes in the relative dominance of components of
mutant spectra are particularly severe during in vivo infections, with complex dynamics of
intra-host heterogeneity and variations. Bioinformatic procedures have been developed to
unveil the relationships among different but closely related genome types that may suggest
some hierarchical order of mutation acquisition or identification of transmission clusters
(examples are Partition Analysis of Quasispecies, PAQ [42] or QUasispecies Evolution, Net-
work-based Transmission Inference, QUENTIN [43]).
Phenotypic reservoirs
The crux of the matter regarding quasispecies implications is that at any given time, the viral
population includes a reservoir not only of genotypic but also of phenotypic variants, confer-
ring upon the population some adaptive pluripotency. Accumulating laboratory and clinical
evidence renders untenable that minority components of mutant spectra should be dismissed
on the grounds of their being neutral. They can participate in selective processes and cannot
be excluded from interpretations of virus behavior. Variation universally involves point
mutations and it can also include recombination (in its replicative and non-replicative
modes), and genome segment reassortment [33]. All modes of molecular variation are com-
patible, only restricted by the scope of mechanisms accessible to the replicative machinery, and
for the need of viral genomes to remain functional. David Evans and colleagues identified
many recombination events associated with enterovirus replication, and only a few recombi-
nants made their way towards continued replication [44]. Recombination can mediate adapt-
ability and virulence [45]. High mutation and recombination rates have led to the conceptual
distinction between mechanistically unavoidable and evolutionarily relevant variation, in con-
nection with the issue of clonal versus non-clonal nature of virus evolution (microbial evolu-
tion in general) [46,47]. Only a minority of the nascent variation during replication can be
successfully propagated. Within limits that are set by biological constraints, each population is
made of an array of variant genomes, with a total number which is commensurate with the
virus population size. To infect a plant, animal or cell culture with 103 infectious units can
have very different consequences than to infect with 1010 infectious units, not only because the
host defense systems may be overwhelmed by the high infectious dose, but also because the
mutant repertoire that engages in adaptive explorations is larger. Part of the variants of a
mutant spectrum, either in isolation or in consortium with others [48], may perform better
than other members of the same population in the event of an environmental change. Selective
pressures favor replication of some components of a mutant spectrum over others, despite all
of them being interconnected by mutation. Differential performance can be at the level of viral
genomes (during replication, intracellular gene expression, interaction with host factors, etc.)
or viral particles (for thermal stability, entry into or exit from cells, to withstand neutralizing
antibodies, etc.) [14,16–18,20,33–35].
Adaptability of RNA viruses is linked to parameters that facilitate exploration of sequence
space: genome size (1.8 to 33 Kb), population size (variable but that can attain an impressive
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1012 individual genomes in an infected host at a given time), replication rate, mutation rate,
fecundity (yield of viral particles per cell), and number of mutations required for a phenotypic
change (surprisingly low for several relevant traits) (see [49]).
Mutant spectrum dynamics has been depicted in different ways, and we have chosen one
that encompasses frequent events in natural populations and research designs, such as virus
isolation from an infected host, adaptation to cell culture for studies on experimental evolu-
tion, or adaptation to alternative hosts in vivo (Fig 3). Despite the complexity conveyed by the
figure, the reality is even more complex, given the large population sizes, with an indetermi-
nate proportion of genomes actively replicating at any given time (sometimes equated with the
effective population size in general genetics), and harboring multiple mutations per genome.
The scenarios suggested by current experimental data defy our imagination. The relative fre-
quency of individual mutations fluctuates in an unceasing exploration of sequence space [50–
52], with phenotypic changes (not only genotypic changes) being far more frequent than previ-
ously thought. The experimental evolution design that consists of passaging viral populations
for long time periods (many sequential infections) is often extremely revealing. In foot-and-
Fig 3. Scope of viral population dynamics. Upon isolation from an infected host (middle boxes), a virus sample may be adapted to cultured cells and subjected to large
population or bottleneck transfers (left box), or be adapted to a different host in vivo (right box). Relevant adaptive mutations are highlighted with colored symbols.
https://doi.org/10.1371/journal.pgen.1008271.g003
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mouth disease virus (FMDV) such a design led to a remarkable phenotypic diversification into
subpopulations of colonizers and competitors, that modulated virulence of the mutant ensem-
ble [53]. In HCV such a design unveiled continuous mutation waves and a more accurate
understanding of the types of fitness landscapes occupied by high fitness viruses [51,54].
Limitations and indeterminacies
The nucleotide sequence of an individual genome from a population (no matter which the
degree of population complexity might be), can be determined either following a biological or
molecular cloning event or by deep sequencing of entire viral genomes, in a manner that muta-
tion linkage (assignment of different mutations to the same genome molecule) can be estab-
lished. Each of these procedures implies some limitations: biological cloning can bias the
representation in favor of infectious genomes, while molecular cloning can introduce non-
infectious (defective) genomes in the analysis [14,49,50]. Whole genome quasispecies descrip-
tion is still technically challenging due to the artifactual introduction of mutations. Most cur-
rent deep sequencing platforms yield sequences of short reads for a given amplicon (sequence
under analysis); minority mutations in an amplicon cannot be reliably linked to mutations in a
different amplicon of the same genome; at most, statistical inferences on linkage can be pro-
posed. Despite these limitations, control experiments and improvements of bioinformatic pro-
cedures support that the majority of sequence heterogeneity analyzed in viral populations
indeed reflects differences in the natural template populations. If mutation linkage can be
solved on a routine basis, a new wave of molecular information relevant to epistatic interac-
tions will enter the picture.
There are additional levels of indeterminacy in the sequential analysis of viral populations,
in particular those replicating in vivo. Components of the mutant spectrum represented at a
given time in the sample taken for sequencing may differ from those in the next time point,
due either to sampling uncertainties or bona fide fluctuations of genome frequencies. It is not
justified to accept a rough similarity because even a single mutation in a given sequence con-
text may affect biological properties [16]. In the words of John Holland and colleagues: “It is
important to remember that every quasispecies genome swarm in an infected individual is
unique and “new” in the sense that no identical population of genomes has ever existed before
and none such will ever exist again” [55]. On top of the fleeting nature of any mutant distribu-
tion, the standard methods available for quasispecies characterization provide genomic
sequences of a minority of the population (estimated in 10−8 to 10−13 for molecular cloning-
Sanger sequencing, and in 10−6 to 10−11 for deep sequencing; reviewed in [49]). We can only
have an approximate representation of viral populations and their dynamics, as evidenced by
many experimental studies [6,12,16,34,35,49,51,56].
Consensus is not enough
The points summarized in previous sections fully justifies addressing analytical tools towards
the mutant spectrum rather than ignoring it or considering its presence a side issue. Use of
consensus sequences to describe the genome of a virus isolate, despite being warranted by the
difficulties of conveying the information recapitulated in a mutant spectrum, blurs and enfee-
bles biological interpretations. Experimental results have demonstrated that minority genomes
from a mutant spectrum (that cannot be identified by examining the consensus sequence) can
include mutations that confer resistance to antiviral inhibitors, neutralizing antibodies or
cytotoxic T cells, or that can alter the capacity to induce interferon (IFN) or to respond to IFN,
virulence or particle stability, among other phenotypic traits [16,33,37,51,56–60]. Mutant spec-
tra can also mediate cyclical adaptation to different cell types [61]. A mutant spectrum defines
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a consensus but the consensus is an abstraction; it may not be represented in the population.
Many events in viral pathogenesis and evolution are due to mutant spectrum modifications or
interactions which cannot be properly interpreted solely on the basis of consensus sequences
[6,14–16,20,32,34,35,44,45,48,51,55].
Collective responses: ensembles as units of selection
Mutant spectra are not mere aggregates of mutants acting independently. They are often
engaged in collective responses of two major types: those that depend on the presence of sets
of variants, and those that rely on intra-mutant spectrum interactions.
Variants that drive responses to selective constraints
Behavior of reconstructed quasispecies. In some cases of sweeping selection (very strong
selection for a trait), an individual (or a limited number of individuals) that encodes signatures
prone to be selected, may approach dominance while becoming the founder of a mutant cloud
(because formation of a cloud is inherent to replication). Conditions for dominance (in this
case in response to selection) are that the genome senses the selective sweep and that its repli-
cation in the new selective environment is permitted. In other cases, a collection of mutants is
selected. This was illustrated with a FMDV quasispecies that was reconstructed in the labora-
tory with multiple antigenic variants (each at low frequency) that belonged to two different
categories, and shared resistance to the same monoclonal antibody [62]. One category
included mutants with an amino acid substitution that affected receptor recognition (since the
antigenic determinant overlapped with the integrin receptor recognition site); in the other cat-
egory, the substitutions affected the antigenic determinant but not the receptor recognition
site. Passages of the virus in absence of the monoclonal antibody resulted in dominance of
antigenic variants that maintained the receptor recognition capacity, but the dominant vari-
ants were surrounded by a cloud of mutants of the other antigenic variant category. Con-
versely, passages in the presence of the antibody led to selection of variants with altered
receptor recognition, surrounded by a cloud of antigenic variants that maintained receptor
recognition. The results underlined the role of mutant clouds in selective events, and unveiled
a new mechanism of antigenic flexibility [62].
Quasispecies memory. Quasispecies memory is a type of molecular memory dependent
on the recent history of the evolutionary lineage and the integrity of the mutant spectrum
[57,63]. The search for memory was prompted by the complex adaptive system behavior of a
viral quasispecies, suggested by the presence of core information (considered the one that
defines viral identity) despite variation of constitutive elements (the mutant spectrum). A well-
known example is memory in the immune system that mobilizes and expands minority com-
ponents in response to stimuli previously faced by the system [64]. In the experiments
designed to identify memory in viral quasispecies, members of the mutant spectrum increased
in frequency as a consequence of their replication during a selection event that drove them
towards dominance. When the selective constraint was withdrawn, memory genomes
remained at levels that were 10- to 100-fold higher than the basal levels attributable solely to
their generation by mutation, as documented with independent FMDV genetic markers, and
with HIV-1 in vivo [57,63,65,66]. Thus, memory is a history-dependent, collective property of
the quasispecies that confers a selective advantage to respond to environmental changes previ-
ously experienced by the same evolutionary lineage. It can be manifested only if the mutant
spectrum maintains its completeness, since memory is lost when the population undergoes a
bottleneck event that excludes minorities. A relevant example of the consequences of memory
occurs in antiviral pharmacology with the administration for a second time of the same or a
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related antiviral agent (capable of evoking shared resistance mutations) used in a previous
treatment. The second intervention may face inhibitor-resistant memory genomes from the
earlier treatment, thus contributing to virus escape [57]. This is an aspect that has not received
adequate attention in the planning of antiviral interventions for patients who fail a first treat-
ment and have to be subjected to a second treatment.
Intra-mutant spectrum interactions for interference, complementation or
cooperation
Individual genomes surrounded by a cloud of related mutants can be either suppressed to be
kept at low frequency, or helped to be maintained in the population. The two alternative fates
are dependent on several factors, one being the surrounding mutant spectrum in those steps of
the infectious cycle in which an effective competition among variants is established, for exam-
ple within replication complexes. This important concept was first derived theoretically [3,67],
and then approached experimentally with several viruses. In an early study, Juan Carlos de la
Torre and John Holland described suppression of high fitness VSV by mutant spectra of infe-
rior fitness [68]. Suppressive effects have since been documented with standard and mutagen-
ized viral populations. Some examples are:
• Suppression of high fitness antigenic variants of FMDV by low fitness antibody-escape
mutants [69].
• Suppression of virulent poliovirus (PV) by attenuated virus in poliovirus vaccines [58].
• Suppression of pathogenic lymphocytic choriomengitis virus (LCMV) (that cause growth
hormone deficiency in mice) by non-pathogenic LCMV variants [70].
• Suppression of FMDV by a mutagenized FMDV population [71].
• Suppression of FMDV by capsid and polymerase FMDV mutants [72].
• Suppression of drug-resistant viral mutants during antiviral therapy [73,74].
Opposite to suppression is maintenance of a mutant either by a favorable position in a fit-
ness landscape or by interactions of complementation or cooperation with members of the
mutant spectrum. The position in a fitness landscape influences vulnerability to mutations, as
popularized with the terms “advantage of the flattest” or “survival of the flattest”, indicating
that a variant located at the top of a sharp fitness peak has higher probability to decrease fitness
as a result of new mutations than the same variant located at a fitness plateau [75–77]. Survival
of the flattest has been also proposed as an ingredient in some models of the error threshold
[78].
Collective behavior of viruses was documented with mutant RNA viruses resistant to nucleo-
tide analogues. The study of this class of mutants has been instrumental for the understanding
of the molecular basis of template copying fidelity, and the consequences of fidelity alterations
in the adaptive capacity and pathogenic potential of RNA viruses [79–81]. In the first mutant
studied, amino acid substitution G46S in the PV polymerase resulted in about four-fold increase
in template-copying fidelity. This modification reduced PV adaptability and infective potential
in vivo [79,80]. The mutant in isolation did not replicate efficiently in the brain of susceptible
mice, but it did when its mutant spectrum was broadened by 5-fluorouracil mutagenesis or
when it was co-inoculated with wild type PV [80].
Complementation (often occurring when a functional protein encoded by a set of genomes
is used by another set of genomes whose encoded protein is not functional) may underlie
some collective responses of quasispecies such as fitness of individuals isolated from a
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population being inferior to fitness of the population [6,7]. Complementation was described
between two truncated FMDV genomic forms [56,82]. The genomes with internal deletions
became detectable upon high multiplicity passage of a clonal population of standard FMDV, a
virus with a monopartite single stranded RNA genome. Infectivity was generated by comple-
mentation of the two truncated forms, in absence of standard, full length FMDV genomes. For
complementation to be effective, prior exploration of sequence space through point mutations
was a requirement [83]. The system underwent a remarkable evolutionary transition akin to
genome segmentation. Drastic genetic lesions in viral genomes are difficult to observe unless a
mechanism such as complementation comes into the rescue of the deviant genomes. Addi-
tional examples of complementation among RNA viruses have been reported ([84–86]; for
review see [33,35]). Complementation is a means to maintain defective genomes at detectable
frequencies in viral populations.
A distinction has been made between complementation and cooperation, in which two dif-
ferent genomes give rise to a new phenotype through the interaction between two variant pro-
teins [87]. An example of cooperation was characterized during studies with measles virus on
membrane fusion which is essential for virus entry into cells. For this virus fusion is mediated
by two proteins termed H and F. A truncated H was deficient in cell fusion but the activity was
regained when the truncated H was accompanied by two forms of F but not one of the forms
individually [87].
Therefore, complementation, cooperation, interference and suppression can emerge from
interactions among components of mutant spectra that have their origin in random mutations.
Selection acts on whatever sets of mutants can provide a useful trait, to turn random occur-
rences into biological meaning.
Bottlenecks: Weakening, liberation, or challenge?
A means to interrupt the participation of individual genomes in interactions with their mutant
spectrum is for the quasispecies swarm to undergo drastic reductions in population size that
isolate one or few individual genomes from their surroundings. Such reductions are termed
bottlenecks (Fig 4), and they have an important participation in shaping evolutionary lineages
for all kinds of organisms, and also for viruses. Bottleneck events are also depicted in Fig 3
(plaque-to-plaque transfers in box at the left). They occur frequently not only upon host-to
host transmission but also inside infected hosts [88–90], and they can perturb positive and
negative selection events in processes that are difficult to identify and characterize.
Drastic bottleneck events have been reproduced with laboratory populations of viruses in
the form of plaque-to-plaque transfers [91,92] (depicted in Fig 3). This design served to verify
experimentally the operation of Müller’s ratchet, or fitness decrease by the irreversible incor-
poration of mutations in asexual organisms in absence of compensatory mechanisms [93]. The
serial bottleneck transfers unveiled the presence of rare mutations, not seen in standard labora-
tory or natural viral populations. In absence of forced bottleneck events, such rare mutations
would be lost by negative selection because of the fitness cost they inflict [94]. The investiga-
tion of how FMDV clones debilitated by Müller’s ratchet regained replicative fitness revealed
several alternative molecular pathways for fitness recovery [95]. The implications of this obser-
vation went largely unnoticed until recent results with hepatitis C virus (HCV) have also sug-
gested the accessibility of multiple pathways for fitness gain [51,54]. Also, extensive passage of
a biological clone of FMDV in BHK-21 cells conferred the capacity to infect several human cell
lines in addition to the expected fitness increase for multiplication in BHK-21 cells [96]. Thus,
several lines of evidence suggest that fitness gain in a specific environment may paradoxically
broaden the phenotypic potential of a virus. It will be interesting to investigate whether
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focused adaptation of other viruses to a specific environment may also entail a broadening of
diversity, with many phenotypic variants attaining similar fitness levels. If generalized, this
broadening of phenotypic space would provide a new interpretation of the molecular basis of
adaptation, and explain why adaptation to alternative environments may not lead to
attenuation.
Deprivation of an individual virus from possible suppression, complementation or cooper-
ation, may represent a liberation to initiate a new evolutionary process, or a condemnation to
extinction. If liberated from suppression, the isolated genome must replicate and be able to
reconstruct a mutant cloud to regain adaptive capability. This has led to the suggestion that
high mutation rates evolved to allow such mutant spectrum recovery following bottlenecks.
Other models attribute high mutation rates to adaptive optimization independent of bottle-
necks, or to a mechanistic consequence of rapid replication (reviewed in [49]). Whatever their
ultimate origins, high mutation rates serve the purpose of adaptation in multiple circum-
stances, not only following bottlenecks. A founder virus can introduce a different phenotype
for the ensuing evolution. Evolution of viruses in nature and as disease agents can be viewed as
succession of mutant spectrum alterations, subjected to expansions and reductions of
Fig 4. Illustration of bottleneck of different severity, defined by the different arrows acting on the entire
populatio. Symbols represent mutation types.
https://doi.org/10.1371/journal.pgen.1008271.g004
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population size in a continuous interplay of positive and negative selection and random drift.
While short-term (for example, intra-host) evolution is observable and measurable, viruses
may appear to be relatively static in the long term for decades (as seen with antigenic variants
of FMDV [97]) or longer. Intra-host evolution is generally more rapid than inter-host evolu-
tion, as documented with viruses [16] and other biological systems [98]. Apparent invariance
may be the result of selection for long-term survival of populations that have previously fren-
ziedly tested evolutionary outcomes in short-term processes [49].
Quasispecies and viral disease
Soon after quasispecies was evidenced for viruses, some medical implications were made
explicit [12,99]. Several specific or general points (reviewed in [16,34,59], and in several chap-
ters of [20]) can be succinctly exposed as follows:
• High mutation rates and population heterogeneity endow viruses with the potential to
escape immune pressures (including those due to vaccination) and antiviral inhibitors used
in therapy. It is an open question if vaccination can promote long-term evolution of anti-
genic determinants.
• Attenuated RNA virus vaccines can revert to virulent forms. RNA viruses released in nature
for pest control purposes can mutate to new phenotypes.
• Virus attenuation and virulence is dependent on viral genetic traits. Variant forms of a given
virus may display increased virulence or atypical disease.
• Components of a mutant spectrum can exhibit a different cell tropism or host range than
most genomes in the same population, with implications for the emergence and re-emer-
gence of viral disease.
• Viral pathogenesis is influenced by microevolutionary processes in which some viral sub-
populations are replaced by others to persist or to invade new cell types, tissues or organs.
• The larger the actively replicating (effective) population size and the replication rate, the
most effective is exploration of sequence space for phenotypic expansions that favor survival
and persistence.
• There is a connection between four parameters that caracterize viruses during infection pro-
cesses: replication rate (the rate at which viral RNA or DNA is synthesized intracellularly for
viral progeny production), viral load (the total amount of virus quantified in an infected host
or host compartment), genetic heterogeneity, and replicative fitness (the yield of infectious
particles that can contribute to the next generation). They can influence disease progression,
and any of them can be targetted for disease control.
In all interactions conductive to disease, the host cells individually and as groups in tissues
and organs play decisive roles. The consequences of a viral infection are always host-depen-
dent. However, the virus itself poses a major challenge that a deeper understanding of quasis-
pecies dynamics is helping to confront.
Antiviral strategies in response to the quasispecies challenge
There is an increasing perception that Darwinian principles should assist in the planning of
antiviral designs [100]. The aim of vaccination is to evoke a protective response that either pre-
vents virus replication or disease. The aim of an antiviral pharmacological intervention is to
inhibit virus replication to provide the immune system with an opportunity to clear the virus.
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Expressed simply, the direct danger for vaccination and treatment is that virus can escape
through selection of mutants resistant to vaccine-triggered defense components or to the
externally administered inhibitors. This has led to several proposals to confront viral disease,
that can be summarized as follows (reviewed in [49]):
Vaccines should expose multiple B cell and T cell epitopes to the immune
system
Vaccines should include repertoires of B cell and T cell epitopes to evoke an ample immune
response. The broad response should minimize selection of escape mutants that may be pres-
ent as minority components in mutant spectra, as repeatedly documented experimentally
[14,16,35,57]. With the current types of available vaccines, those that best comply with the
multiple epitope requirement are, in the order of expected efficacy to confer protection against
highly variable viruses: attenuated > inactivated whole virus > several expressed proteins >
one expressed protein > multiple synthetic peptide antigens > single peptide antigen. The
scarcity of effective synthetic vaccines for RNA viral pathogens despite huge scientific and eco-
nomic efforts is a reflection of the underlying problems.
Antiviral agents should be used in combination
Antiviral monotherapy (use of a single antiviral agent) is to be avoided. The following recom-
mendations have been made and in some cases successfully implemented:
• Inhibitors used in combination should target different viral gene products.
• Splitting a treatment into two steps: first an induction regimen, and a second maintenance
regimen. Drugs administered in the two steps should be different.
• Targetting of cellular functions needed for the virus life cycle.
• Use of innate immune response-stimulating drugs (for example, inhibitors of enzymes
involved in pyrimidine biosynthesis).
• Combined use of immunotherapy and chemotherapy.
• Lethal mutagenesis or virus extinction by excess of mutations introduced during viral
replication.
These strategies (whose supportive theoretical and experimental evidence has been
reviewed in [49,60]) have as their main objective to avoid selection of treatment-escape
mutants by multiple selective constraints that cannot be surmounted by the virus. Control is
effective either because exploration of sequence space cannot reach the required multiple
mutations (even when recombination is available) or because the multiple mutations inflict a
severe fitness cost [101]. Vaccines exposing multiple epitopes and combination therapies fol-
low the same strategy whose aim is to limit possible escape routes to viral quasispecies in the
face of the suppressive constraint.
Lethal mutagenesis
Lethal mutagenesis is the process of virus extinction at the error rate at which a virus can no
longer maintain its genetic information [16,20,35,49,54,78,102,103]. Application of lethal
mutagenesis as an antiviral strategy deserves attention in the context of the present article
because its origins lie in quasispecies theory, in the form of the error threshold relationship
(Fig 1). Both the error threshold and lethal mutagenesis are highly fitness landscape-
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dependent, but both can occur in complex fitness landscapes as those pertinent to viral popula-
tions [5]. The term lethal mutagenesis was coined by Lawerence Loeb and colleagues [102],
and it is now widely used to describe the antiviral activity of base and nucleoside analogues
that increase the viral mutation rate. Although several models have been proposed to account
for virus extinction by excess mutations [78], an extension of the violation of the error thresh-
old stands as a likely mechanism ([104]; recent review in [103]). Interestingly, some antiviral
agents licensed for human use, initially thought to act only as inhibitors of viral replication,
may actually exert their antviral activity against some RNA viruses at least partially by lethal
mutagenesis. This is the case of favipiravir (T-705; 6-fluoro-3-hydroxy-2-pirazinecarboxa-
mide) and ribavirin (1-β-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide) that are cur-
rently being intensively investigated as lethal mutagens [103].
Defense mechanisms based on genome modification of invading genetic parasites such as
editing cellular activities that are recruited as part of the innate immune response (ADAR,
APOBEC, RIP, etc; reviewed in [105]) represent a natural counterpart of the principle utilized
by lethal mutagenesis. Applicability to pathogenic cellular elements is a real possibility, and
lethal mutagenesis to control tumor cells is an active field of investigation [106,107]. Thus, the
recognition of quasispecies dynamics has suggested some fundamental guidelines for disease
prevention and control that are gradually permeating clinical practice. This is in line with the
recognized need to apply Darwinian principles to the control of infectious disease.
Summary and prospects
The main concepts covered in the present article and their domains of applicability are sum-
marized in Table 1. The adequacy of quasispecies theory (versus other formulations of evolu-
tionary dynamics [108]) as a framework for the error-prone replication of viruses and its
consequences stems from its including mutation as an integral part of the replication process
Table 1. Summary of main concepts related to quasispecies and their implications a.
Concept Implications for virology References
Error-prone replication and
mutant spectra
Limited template-copying fidelity leads to formation of dynamic mutant distributions. They mediate virus
adaptability.
[1,6,9,13]
Phenotypic reservoir Mutant spectra are a phenotypic reservoir for selection to act upon [16,17,20]
Adaptive parameters Viral quasispecies adaptability relies on six parameters: genome size; population size; replication rate; mutation




Mutant spectra are not mere mutant aggregates. Emergent behavior can result from positive interactions of




Quasispecies memory A record of past genome dominances that prepares a viral population to respond to a selective constraint
previously experienced by the same lineage. Bottlenecks erase quasispecies memory.
[57,63,65,66]
Sequence space The total number of genomic sequences available to a virus. Adaptation is a movement towards a favorable
region of sequence space. De-adaptation (i.e. lethal mutagenesis) is a movement towards unfavorable regions of
sequence space.
[2,14,37,49]
Population bottleneck A drastic reduction in population size. It promotes random drift in evolutionary outcomes. The diversifying
effect of bottlenecks is accentuated by the cloud nature of viral populations.
[88,90,91,94]
Biological constraints High mutation rates expand sequence space occupation. Biological constraints impose negative selection on




Progress of an infection is often associated with virus adaptation to host environments. Variants of the same




Short-term evolutionary rate based on reorganization of mutant spectra is faster than long-term evolutionary
rate. Conceptual links between quasispecies and phylodynamics at the epidemiological level are needed.
[111]
aConcepts are listed in the order relevant to the topics covered in the text, and serve to underline key points and some supportive studies. The concepts are expanded in
the text, with additional references.
https://doi.org/10.1371/journal.pgen.1008271.t001
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[13]. Quasispecies dynamics poses a great challenge for the molecular interpretation of short-
term evolutionary events that bear on virus-host interactions and disease processes. A reward-
ing aspect of progress in having captured the meaning of the challenge (at least partially) is
that we can exclude some of the prevention and control strategies that once were considered
an option. A significant example is the historical rejection of combination therapies as con-
trary to the established canons of pharmacology, while now monotherapy is considered a risky
practice (for discussion of this point, see [49]). We understand now that focused antiviral bar-
riers that involve a single constraint (one inhibitor, one monoclonal antibody, one peptide
antigen as vaccine) have a large probability of failing. Likewise, attempts to produce “univer-
sal” drugs, vaccines or diagnostic tools are unlikely to succeed given the intra-population
diversity (present and potential) of the pathogenic agents to be controlled. A viral genome
region which is conserved among types, subtypes, isolates may be so only regarding a consen-
sus sequence but not the underlying mutant spectrum. Methods are now available to identify
low level mutations that may predict escape from selective constraints. On a related note, it
remains extremely unlikely to predict the emergence and re-emergence of viral diseases for a
number of interconnected reasons, not the least important being pathogen adaptability [109].
The outlined limitations to predict the occurrence of viral diseases and to control them are
based on our current understanding of viral complexity and dynamic change of such complex-
ity. Obviously, we may be wrong, and in science we are open to the unexpected.
Quasispecies poses also a challenge for the annotation of the events we witness. Reality is
far more complex than the means we have developed to describe viral populations in continu-
ous change. How could the problem we approached? Procedures to organize and relate
sequences for phylodynamic purposes need updating to exploit increased computing power to
handle mutant spectra rather than one or few (consensus or other) sequences from each bio-
logical sample. The expanding number of sequences expected to become available including
complete genomes (that will allow mutation linkage to enter the picture) if handled properly,
may inform of the molecular basis of new phenotypes. The penetration into mutant spectra
has also modified the concept of rare mutation since what in terms of consensus could be cata-
logued as rare may in fact be frequently occurring but rarely observed. A mutation which has
low frequency at one time point or in a given environment may rise to high frequency at
another time point or in a different environment. Rare mutations that populate mutant
swarms may belong to defective genomes exerting relevant host interactions [110]. On a more
general note, recognition of viral quasispecies was premonitory of the impressive diversity in
the biological world that the metagenomic approaches are currently unveiling, including cellu-
lar heterogeneities whose biological implications remain largely unexplored.
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